Market Cap
$231.0M
AMWL
American Well Corp
$12.39 ▼ -3.35%
Prev close $12.82Market cap$231.0M
ConsensusHold
12-mo target$12.80 (+3.3%)
▲ Neutral
Analyst conviction 4/10
Insider Selling Cluster (3 insiders)7 New Institutional Positions3 Institutional Exits Software & IT
Snapshot
The big-picture read on AMWL right now — valuation, ownership and activity at a glance.
Cap Size
Micro Cap
Analyst Consensus
Hold (40%)
Inst. Holders
41 funds
Inst. Value
$38.1M
Inst. Activity
7 buys / 3 sells
Insider Activity
$4.9K buy / $724.6K sell
Insider Net $
-$719.7K
SEC Reports
12
Press Releases
1
Price chart 30d -6.5%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 8, 2026 contract
Sep 4, 2026 SEC Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure
Amwell receives Letter of Intent from Department of Veterans Affairs to be its enterprise virtual he
Three American Well insiders (CFO, CAO, President International) sold a combined ~$170K in open-market transactions on S
CLUSTER — Impact 2/10
Sep 1, 2026 Insider
HIRSCHHORN MARK sold 10,751 shares
Chief Financial Officer @ $11.80 ($126.9K)
Sep 1, 2026 Insider
McNeice Paul Francis sold 112 shares
Chief Accounting Officer @ $11.80 ($1.3K)
Sep 1, 2026 Insider
Aug 4, 2026 SEC Gotlib Phyllis sold 3,573 shares
President, International @ $11.80 ($42.2K)
Amwell Q2 2026 revenue of $52.0M was at the top end of guidance, but total revenue declined 26.6% YoY from $70.9M. Net l
8-K — Impact 6/10
Officer Mark Hirschhorn filed Form 144 to sell 4,299 Class A shares (approx. $40K) solely to cover taxes upon RSU vestin
144 — Impact 2/10
Jun 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
263,223 shares ($2.4M)
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
40% rate it Buy or better · 15 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 13, 2026 | Truist Securities | MAINTAIN | Hold | 55% |
| Aug 5, 2026 | Needham | REITERATE | Hold | 50% |
| Jul 17, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| May 6, 2026 | TD Cowen | MAINTAIN | Hold | 56% |
| May 6, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| Aug 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| Jul 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| Jun 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| May 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| Apr 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| Mar 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% | |
| Feb 1, 2026 | 2 | 4 | 9 | 0 | 0 | 40% |
Price targets
Where 5 covering analysts think AMWL trades over the next 12 months.
$12.80 +3.3% upside Hold
Current$12.39 Low$11.00 Median$12.00 High$16.00 5 analysts
$11.00$16.00
Analyst rating None as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
12 SEC filing reports analyzed · 0 bullish, 1 bearish, 2 mixed, 9 neutral · avg impact 3.2/10.Plus 1 press releases.
NEUTRALCLUSTER2/10
Three American Well insiders (CFO, CAO, President International) sold a combined ~$170K in open-mark
Sep 4, 2026
MIXED8-K6/10
Amwell Q2 2026 revenue of $52.0M was at the top end of guidance, but total revenue declined 26.6% Yo
Aug 4, 2026
NEUTRAL1442/10
Officer Mark Hirschhorn filed Form 144 to sell 4,299 Class A shares (approx. $40K) solely to cover t
Jul 3, 2026
NEUTRALCLUSTER2/10
Four insiders at American Well Corp (AMWL) sold a total of ~$187K in open-market transactions on Jul
Jul 2, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 8, 2026
contract
Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure
Amwell receives Letter of Intent from Department of Veterans Affairs to be its enterprise virtual health platform.
Sep 3, 2026
routine
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 U
Sep 2, 2026
other
Amwell® to participate in upcoming investor conferences
BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the A
Aug 4, 2026
earnings
Amwell® Announces Results for the Second Quarter 2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platfo
Aug 4, 2026
earnings_calendar
AMWL Q2 2026 Earnings After Market Close — 2026-08-04
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.66 | $-0.66–$-0.66 | 57.5% | -6.5% | 0↑ 1↓ | $0.0B | 1 |
| Next Q | $-0.44 | $-0.44–$-0.44 | 60.9% | +30.2% | 1↑ 0↓ | $0.0B | 1 |
| Current FY | $-2.56 | $-2.56–$-2.56 | 19.8% | +4.5% | 1↑ 0↓ | $0.2B | 1 |
| Next FY | $-1.58 | $-1.58–$-1.58 | 38.3% | +6.0% | 1↑ 0↓ | $0.2B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.660 | — |
| 7d ago | $-0.620 | -0.040 |
| 30d ago | $-0.620 | -0.040 |
| 60d ago | $-0.620 | -0.040 |
| 90d ago | $-0.620 | -0.040 |
Institutional ownership
Which big funds own AMWL (from quarterly 13F filings) and who is adding or trimming.
41 institutional holders with $38.1M total value (4,201,602 shares) as of 2026-Q2. Top holders: MORGAN, VANGUARD, BlackRock,. Net buying activity: 7 institutions added/increased vs 3 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| MORGAN STANLEY | 1,278,429 | $11.7M | 30.6% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 611,259 | $5.6M | 14.6% | — |
| BlackRock, Inc. | 427,576 | $3.9M | 10.2% | ADD +46.7% |
| RENAISSANCE TECHNOLOGIES LLC | 263,223 | $2.4M | 6.3% | ADD +35.0% |
| Russell Investments Group, Ltd. | 182,243 | $1.7M | 4.4% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 158,623 | $1.4M | 3.8% | — |
| TWO SIGMA INVESTMENTS, LP | 145,104 | $1.3M | 3.5% | DOUBLED +135.1% |
| JANE STREET GROUP, LLC | 141,282 | $1.3M | 3.4% | DOUBLED +161.1% |
| DIMENSIONAL FUND ADVISORS LP | 122,501 | $1.1M | 2.9% | ADD +37.6% |
| MARSHALL WACE, LLP | 108,057 | $985.5K | 2.6% | DOUBLED +145.3% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | ADD | 195,023 | 263,223 | +35.0% | $2.4M |
| JANE STREET GROUP, LLC | DOUBLED | 54,112 | 141,282 | +161.1% | $1.3M |
| DIMENSIONAL FUND ADVISORS LP | ADD | 88,996 | 122,501 | +37.6% | $1.1M |
| MARSHALL WACE, LLP | DOUBLED | 44,045 | 108,057 | +145.3% | $985.5K |
| GOLDMAN SACHS GROUP INC | TRIM | 123,597 | 81,729 | -33.9% | $745.4K |
| UBS Group AG | DOUBLED | 4,690 | 48,517 | +934.5% | $442.5K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | TRIM | 31,386 | 12,374 | -60.6% | $112.9K |
| SIMPLEX TRADING, LLC | ADD | 982 | 1,745 | +77.7% | $15.9K |
| ROYAL BANK OF CANADA | NEAR_EXIT | 1,557 | 186 | -88.1% | $1.0K |
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | 21,998 | 28,654 | +30.3% | $262.00 |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
11 insiders, 29 transactions. Net -$719.7K — $4.9K bought, $724.6K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | HIRSCHHORN MARK | Chief Financial Officer | SELL | 10,751 | $11.80 | $126.9K |
| Sep 1, 2026 | McNeice Paul Francis | Chief Accounting Officer | SELL | 112 | $11.80 | $1.3K |
| Sep 1, 2026 | Gotlib Phyllis | President, International | SELL | 3,573 | $11.80 | $42.2K |
| Jul 1, 2026 | Zamansky Dmitry | Chief Product & Tech. Officer | SELL | 8,460 | $9.33 | $78.9K |
| Jul 1, 2026 | McNeice Paul Francis | Chief Accounting Officer | SELL | 653 | $9.33 | $6.1K |
| Jul 1, 2026 | HIRSCHHORN MARK | Chief Financial Officer | SELL | 4,299 | $9.33 | $40.1K |
| Jul 1, 2026 | Gotlib Phyllis | President, International | SELL | 6,677 | $9.33 | $62.3K |
| Jun 16, 2026 | Goldwasser Rivka | Director | AWARD | 14,501 | — | — |
| Jun 16, 2026 | Jackson Deborah C | Director | AWARD | 14,501 | — | — |
| Jun 16, 2026 | Schlegel Stephen J. | Director | AWARD | 14,501 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for AMWL.
Shares short
160,460
Settlement Sep 15, 2026
Change vs prior
+21.4%
Semi-monthly cycle
Days to cover
1.4
At avg daily volume
Of shares outstanding
≈0.9%
Estimate — not % of float
All AMWL filing & press-release reports (13)
- CLUSTER reportSep 4, 2026
- 8-K reportAug 4, 2026
- 144 reportJul 3, 2026
- CLUSTER reportJul 2, 2026
- DEFA14A reportJun 9, 2026
- CLUSTER reportJun 3, 2026
- 144 reportJun 1, 2026
- PRESS-RELEASE reportMay 18, 2026
- 8-K reportMay 12, 2026
- 8-K reportMay 5, 2026
- DEFA14A reportApr 23, 2026
- CLUSTER reportMar 6, 2026
- CLUSTER reportMar 3, 2026